Clinical studies show that cytoplasmic localization of APE1 correlates with increased aggressiveness and poor prognosis in several cancer types, including lung cancer28, ovarian cancer29, breast cancer30, and hepatocellular carcinoma31. The gene discussed is APEX1; the disease is cancer.